Scinai Immunotherapeutics Ltd. Stock
Scinai Immunotherapeutics Ltd. dominated the market today, gaining €0.045 (4.620%).
Our community identified positive and negative aspects for Scinai Immunotherapeutics Ltd. stock for the coming years. 1 users see the criterium "Management" as a plus for the Scinai Immunotherapeutics Ltd. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Scinai Immunotherapeutics Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'